Department of Community Medicine, Federal University Dutse, Jigawa, Niger Republic.
Department of Internal Medicine, Federal University Dutse, Jigawa, Niger Republic.
Niger Postgrad Med J. 2024 Jul 1;31(3):247-254. doi: 10.4103/npmj.npmj_96_24. Epub 2024 Sep 2.
The objective of this study was to identify the factors associated with the outcome of the 2023 diphtheria outbreak in Jigawa State, Nigeria.
A descriptive cross-sectional study was conducted amongst all line-listed diphtheria cases reported from Jigawa State, Nigeria, using the 2023 Integrated Disease and Surveillance Response line list of cases that met the World Health Organization case definition of diphtheria. A total of 245 line-listed cases from January 2023 to December 2023 met the criteria for inclusion in the study. Data were analysed using IBM SPSS version 22.0 with a P value set at ≤5%. Binary logistic regression was used to identify the independent predictors of the outcome of the 2023 outbreak.
The maximum age of the line-listed cases was 39 years, and the minimum was 1 year with a median of 8 (interquartile range = 5-8) years. More than two-thirds (68.2%) of the cases were ≥5 years of age. More than one-third of the cases (39.6%) were from the northeast senatorial zone of the state. Out of the total 245 cases, 14 died of the disease representing a case fatality rate of 6%, and an attack rate of 3.4 per 100,000 populations. The majority of the cases (95.5%) had fever, cough (81.2%), pharyngitis (86.9%), tonsillitis (96.7%) and laryngitis (82.0%). More diphtheria-related mortalities were recorded amongst cases <5 years of age (7.7%), female cases (5.9%), rural residence (7.7%) and cases from the northeast senatorial zone (8.2%) of the state. Significantly higher mortalities (8.8%, P = 0.003) were recorded amongst cases with nasopharyngitis. The odds of diphtheria-related mortality were higher amongst cases who presented clinically with nasopharyngitis and were 4 times more likely to die (adjusted odds ratio = 3.9; 95% confidence interval = 1.1-14.3) compared with those with no nasopharyngitis.
Significantly higher mortalities were recorded amongst diphtheria cases whose samples were not taken, and those with nasopharyngitis. These findings underscored the importance of improved immunisation uptake, early and prompt case detection, investigation and proper management.
本研究旨在确定与 2023 年尼日利亚吉加瓦州白喉疫情结局相关的因素。
采用描述性横断面研究,纳入 2023 年 1 月至 12 月期间在尼日利亚吉加瓦州报告的所有符合世界卫生组织白喉病例定义的白喉病例。共有 245 例符合纳入标准的线列表病例纳入研究。使用 IBM SPSS 版本 22.0 进行数据分析,P 值设为≤5%。采用二元逻辑回归分析确定 2023 年疫情结局的独立预测因素。
线列表病例的最大年龄为 39 岁,最小年龄为 1 岁,中位数为 8 岁(四分位距=5-8 岁)。超过三分之二(68.2%)的病例年龄≥5 岁。超过三分之一(39.6%)的病例来自该州东北部的参议员区。在总共 245 例病例中,有 14 例死亡,病死率为 6%,发病率为每 10 万人 3.4 例。大多数病例(95.5%)有发热、咳嗽(81.2%)、咽炎(86.9%)、扁桃体炎(96.7%)和喉炎(82.0%)。年龄<5 岁(7.7%)、女性(5.9%)、农村居住(7.7%)和来自该州东北部参议员区(8.2%)的病例中,白喉相关死亡率更高。有明显更高的死亡率(8.8%,P=0.003)记录在有鼻咽炎症的病例中。有鼻咽炎症的白喉病例死亡的可能性更高,其死亡的可能性是没有鼻咽炎症的病例的 4 倍(调整后的优势比=3.9;95%置信区间=1.1-14.3)。
未采集样本的白喉病例和有鼻咽炎症的白喉病例死亡率明显更高。这些发现强调了提高免疫接种率、早期和及时发现病例、调查和妥善管理的重要性。